Metabolic activation and hepatotoxicity
Pramlintide, the first generation (1990s) In the 1990s, the pharmaceutical company Amylin Pharmaceuticals developed Pramlintide , a modified amylin with three proline substitutions at positions 25, 28 and 29
Treating one without addressing the other produces incomplete results
When you take an injection every seven days, you are essentially topping off the medication just as the previous dose is reaching its half-way point of elimination
Acetylcholinesterase inhibitors and Gulf War illnesses
doi:10.1016/j.biocel.2012.08.016, PMID: 22939972 Zeevalk GD, Manzino L, Sonsalla PK, Bernard LP (2007) Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinsons disease